Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maternal Tdap vaccination and infant immune response
2013-003090-98Phase 4Completed
- Sponsor
- National Institute for Public Health and the Environment
- Start
- Sep 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of tetanus toxoid + reduced diphtheria toxoid + acellular pertussis vaccine in pertussis (2 arms), sponsored by National Institute for Public Health and the Environment. Started Sep 2013; status: completed.
02
Drugs
tetanus toxoid + reduced diphtheria toxoid + acellular pertussis vaccine
03
Conditions
pertussis
Beyond the preview
Go deeper on 2013-003090-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003090-98.